Troy Wilson

Hertz Fellow: Troy Wilson
School

University of California, Berkeley

Area of Study

Chemistry

Fellowship Years

1990 - 1995

Troy Wilson is a successful, serial entrepreneur. His passion is to build exceptional companies that create significant value for employees, investors and, most importantly, patients. He is a co-founder of Kura Oncology, Inc., and he has served as President and Chief Executive Officer and as a member of the board of directors since August 2014. Dr. Wilson has served as President and Chief Executive Officer of Wellspring Biosciences LLC, a private biopharmaceutical company, and its parent company Araxes Pharma LLC since July 2012 and as President and Chief Executive Officer of Avidity Biosciences LLC, a private biopharmaceutical company, since November 2012. Dr. Wilson served as the President and Chief Executive Officer and a member of the board of directors of Intellikine, Inc., a private biopharmaceutical company, from April 2007 to January 2012 and from August 2007 to January 2012, respectively, until its acquisition by Takeda Pharmaceuticals. He has also been a member of the board of directors of Puma Biotechnology, Inc., a public biopharmaceutical company, since October 2013, a member of the board of directors of Zosano Pharma, Inc., a public biopharmaceutical company, since June 2014, and a member of the board of managers of Araxes Pharma LLC, a private biopharmaceutical company, since May 2012, a member of the board of managers of Avidity Biosciences LLC since November 2012 and a member of the board of managers of Wellspring Biosciences LLC since May 2012. Troy holds a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley and a J.D. from New York University School of Law.